Melasmonil Peel

565

Step-by-step clinical application guide for practitioners

Depth
Very Superficial
Contact
5–15 min
Neutralize
Requires neutralization
Fitzpatrick
II–VI
Sessions
6–8
Downtime
1–3 days

Overview

Step-by-step clinical application guide for practitioners

01

Safety

Contraindications

  • Active skin infections in treatment area
  • Compromised skin barrier
  • Pregnancy or breastfeeding
  • Isotretinoin use within the last 6 months
  • Topical tretinoin use within 72 hours
  • Open wounds or broken skin in treatment area
  • Known allergy to any component

Wash Off Immediately If

  1. Severe burning or pain
  2. Excessive redness
  3. Hives or welts (urticaria)
  4. Blistering

Stop the procedure and neutralize with cold water or sodium bicarbonate.

02

Composition

IngredientConcentrationRole
Glycolic AcidGentle surface exfoliation, loosens corneocyte bonds for mild desquamation
Lactic AcidHydrating exfoliation, supports ceramide synthesis, gentle surface renewal
Citric AcidAntioxidant buffer, brightening effect, supports pH stabilization
Kojic AcidTyrosinase inhibition, blocks melanin synthesis at enzymatic level
03

Indications

Fitzpatrick II–VI
  • Sensitive Melasma
  • Rosacea-Prone Skin
  • First-Time Peels
04

Procedure

  1. 01

    Cleanse & Degrease

    2–3 min

    Cleanse with gentle non-residue cleanser. Remove makeup, sunscreen, surface impurities. Degrease skin using pre-peel degreasing solution with gauze.

    • Degreasing contact: 1–2 minutes. Wipe clean. Allow skin to dry for 30 seconds.
  2. 02

    Patch Test

    10 min

    Apply a small amount behind the ear or on the inner forearm. Observe for 10 minutes for any adverse reaction.

    • First session only. If erythema, itching, or swelling occurs, do not proceed.
  3. 03

    Apply prodermic 565

    2–3 min

    Apply 1–1.25ml of product using a fan brush or gauze. Apply gently in thin, even layers. This is a gentle formulation suitable for sensitive skin.

    • Gentle application. Avoid excessive layering.
  4. 04

    Observe Initial Response

    3–5 min

    Monitor the skin for 3–5 minutes in-clinic. Ensure no adverse reaction. Mild warmth is normal and expected.

    • If excessive redness, burning, or hives appear, wash off immediately.
  5. 05

    Clinician-Controlled Contact

    5–15 min

    Monitor continuously for 5–15 minutes. Final timing depends on Fitzpatrick type, barrier integrity, treatment history, and live skin response.

    • The treating doctor’s endpoint decision is final; stop earlier for excessive erythema, burning, hives, or escalating discomfort.
  6. 06

    Neutralize & Recover

    2–3 min

    Apply neutralizer according to protocol, remove all residue, rinse with cool water, and apply recovery moisturizer.

    • No actives or makeup for the rest of the day. Apply SPF 50+ before sun exposure.
05

Post-procedure

Daily regimen
Day 0Peel Day Neutralize fully in clinic, rinse with cool water, and apply recovery moisturizer. No actives/makeup.
Day 1Mild Tightness Mild tightness possible. Gentle cleanser 2x daily. Thick moisturizer. SPF 50+.
Days 1–2Very Mild Flaking Very mild flaking may occur. Some patients may not peel visibly at all. Continue moisturizer + SPF 50+.
Day 3+Smoother Skin Skin appears smoother and brighter. Resume light makeup if desired.
Days 5–14Between Sessions Strict sun protection. Resume normal skincare. Next session in 10–14 days.
06

Session plan

Sessions
6–8
Interval
10–14 days
Downtime
1–3 days
Total
2–3 months
Progressive dose schedule
SessionContact time
Session 15 min starting window
Session 25–10 min, response-led
Session 3Up to 10–15 min if clinically appropriate
Session 4+Maximum 15 min; endpoint overrides timer
07

Expected results

Clinical outcomes from supervised sessions. Actual results depend on skin type, adherence to protocol, and sun protection.

Case 01
Case 02
Case 03
Case 04